Last updated: January 18, 2023
Sponsor: University Hospital, Linkoeping
Overall Status: Active - Enrolling
Phase
N/A
Condition
Angina
Chest Pain
Myocardial Ischemia
Treatment
N/AClinical Study ID
NCT04783701
CoCAP
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Previously included in TACSI-trial
Exclusion
Exclusion Criteria:
- Highly irregular heart rhythm (i.e. atrial fibrillation)
- Chronic kidney disease with estimated glomerular filtration rate (eGFR) <45ml/min/1,73m2
- Body weight >120 kg
- Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-basedcontrast agents
- Not able to communicate
- Not willing to participate
Study Design
Total Participants: 360
Study Start date:
May 17, 2021
Estimated Completion Date:
October 01, 2025
Connect with a study center
Department of Heart Disease, Haukeland University Hospital
Bergen,
NorwaySite Not Available
St Olavs University Hospital
Trondheim,
NorwaySite Not Available
University Hospital Linköping
Linköping, Östergötland 58185
SwedenSite Not Available
Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine
Gothenburg,
SwedenSite Not Available
Department of Cardiothoracic Surgery Karolinska University Hospital
Stockholm,
SwedenSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.